drugset / Trial / NCT06740422
Xuanhuang Runtong Tablet in the Treatment of Constipation (Yin-deficiency Type)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This trial is a randomized, double-blind, placebo-controlled parallel-group, multicenter Phase III clinical trial. It is to evaluate the efficacy and safety of Xuanhuang Runtong Tablets in subjects with constipation (Yin-deficiency type) after 4 weeks of treatment.
Timeline
- Start
- 2024-12-15
- Primary completion
- 2026-12-15
- Completion
- 2027-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Xuanhuang Runtong Tablet | Unknown | 7.36 g | — |